| Literature DB >> 34473333 |
Tannaz Jamialahmadi1,2, Paul C Guest3,4, Aida Tasbandi5, Khalid Al-Rasadi6, Amirhossein Sahebkar7,8,9.
Abstract
Disturbances in the prooxidant-antioxidant balance can occur in metabolic syndrome. Here, we present a protocol for the setup of a clinical trial of metabolic syndrome patients treated with berberine, a dietary phytochemical of the Berberis vulgaris plant, or placebo. The main aim is to obtain a quick and real-time assessment on the overall redox state based on measurement of the prooxidant-antioxidant balance.Entities:
Keywords: Barberry; Metabolic syndrome; Natural products; Prooxidant–antioxidant balance; Reactive oxygen species
Mesh:
Substances:
Year: 2022 PMID: 34473333 DOI: 10.1007/978-1-0716-1558-4_22
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745